Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects

Immunobiology

Volumn 216, Issue 1-2, 2011, Pages 80-85

  Malik, Mazhar ^a   Sheikh, Ashfaq M ^a   Wen, Guang ^a   Spivack, Warren ^a   Brown, William T ^a   Li, Xiaohong ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Apoptosis; Autism; Bcl2; Cathepsin D; Cytokines; Inflammation

Indexed keywords

CATHEPSIN D; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD;

APOPTOSIS; AUTISTIC DISORDER; CATHEPSIN D; CELLS, CULTURED; CHILD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649525669     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.03.001     Document Type: Article

References (45)

1. Araghi-Niknam M., Fatemi S.H. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell. Mol. Neurobiol. 2003, 23:947-951.
2. Ashwood P., Wakefield A.J. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 2006, 173:126-134.
3. Baron C.A., Liu S.Y., Hicks C., Gregg J.P. Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J. Autism Dev. Disorders 2006, 36:973-982.
4. Bauman M.L., Kemper T.L. Neuroanatomic Observation of the Brain in Autism. The Neurobiology of Autism 1994, John Hopkins University, Baltimore, pp. 119-145.
5. Beutler B., Cerami A. The biology of cachectin/TNF-a primary mediator of host response. Annu. Rev. Immunol. 1989, 7:625-655.
6. Benes F.M., Lim B., Matzilevich D., Subburaju S., Walsh J.P. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(52):20935-20940.
7. Chez M.G., Burton Q., Dowling T., Chang M., Khanna P., Kramer C. Meantime as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J. Child Neurol. 2007, 22:574-579.
8. Conus S., Perozzo R., Reinheckel T., Peters C., Scapozza L., Yousefi S., Simon H.U. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 2008, 205:685-698.
9. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 2002, 45:1-6.
10. Deiss L.P., Feinstein E., Berissi H., Cohen O., Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kDa protein as potential mediators of gamma interferon-induced cell death. Genes Dei. 1995, 9:15-30.
11. Deiss L.P., Galinka H., Berissi H., Cohen O., Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J. 1996, 15:3861-3870.
12. Erdmann S., Ricken A., Hummitzsch K., Merkwitz C., Schliebe N., Gaunitz F., Strotmann R., Spanel-Borowski K. Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures. Eur. J. Cell. Biol. 2008, 87:311-323.
13. Fatemi S.H., Earle J.A., McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 2000, 5(6). pp. 654-663, 571.
14. Fatemi S.H., Halt A.R. Altered levels of Bcl-2 and P53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse 2001, 15:281-284.
15. Fatemi S.H., Halt A.R., Stary J.M., Realmuto G.M., Jalali-Mousavi M. Reduction in anti-apoptotic protein Bcl2 in autistic cerebellum. NeuroReport 2001, 12:929-933.
16. Folstein S.E., Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2001, 2:943-955.
17. Fusek M., Vetvickova J., Vetvicka V. Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects. J. Interferon Cytokine Res. 2007, 27:191-199.
18. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57:1061-1069.
19. Harris M.H., Thompson C.B. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 2000, 7(12):1182-1191.
20. Heinrich T.W., Junig J.T. Recurrent mania associated with repeated brain injury. Gen. Hosp. Psychiatry 2004, 26(6):490-492.
21. Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., Hourihane J.O., Martin N.D., Walsh C.A. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet. 2000, 26:93-96.
22. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991, 66:233-243.
23. Jarskog L.F., Gilmore J.H., Selinger E.S., Lieberman J.A. Cortical Bcl2 protein expression and apoptotic regulation in schizophrenia. Biol. Psychiatry 2000, 48:641-650.
24. Jyonouchi H., Sun S., Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 2001, 120:170-179.
25. Jyonouchi H., Sun S., Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002, 46:76-84.
26. Laster S.M., Wood J.G., Gooding L.R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 1988, 141:2629-2634.
27. Li X.L., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
28. Li X., Sheikh A., Chauhan A., Chauhan V., Gong C.X., Liu F., Brown W.T., Malik M. BDNF-Akt-Bcl2 anti-apoptotic signaling pathway is compromised in the brain of autistic children. IMFAR 2009, 2009.
29. Lin J.K., Chou C.K. In vitro apoptosis in the hepatoma cell line induced by transforming growth factor-beta. Cancer Res. 1992, 52:385-388.
30. Margolis R.L. cDNAs with long CAG trinucleotide repeats from human brain. Hum. Genet. 1997, 100:114-122.
31. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 2006, 172:198-205.
32. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 1986, 73(4):320-326.
33. Nelson K.B., Grether J.K., Croen L.A. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 2001, 49:597-606.
34. Novelli F., Di Pierro F., Francia di Celle P., Bertini S., Affaticati P., Garotta G., Forni G. Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J. Immunol. 1994, 152:496-504.
35. Pickering M., Cumiskey D., O'Connor J.J. Actions of TNF-α on glutaminergic synaptic transmission in the central nervous system. Exp. Physiol. 2005, 90:663-670.
36. Reid W.A., Valler M.J., Kay J. Immunolocalization of cathepsin D in normal and neoplastic human tissues. J. Clin. Pathol. 1986, 39:1323-1330.
37. Ritvo E.R., Freeman B.J., Schweibel A.B., Duong T., Robinson H., Guthrie D., Ritvo A. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report. Am. J. Psychiatry 1986, 143:862-866.
38. Saftig P., Hetman M., Schmahl W., Weber K., Heine L., Peters C. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 1995, 14:3599-3608.
39. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 1996, 66:143-145.
40. Suda T., Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 1994, 179:873-879.
41. Trauth B.C., Klas C., Peters A.M., Matzku S., Moller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibodymediated tumor regression by induction of apoptosis. Science 1989, 245:301-305.
42. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
43. Whitaker J.N., Rhodes R.H. The distribution of cathepsin D in rat tissues determined by immunocytochemistry. Am. J. Anat. 1983, 166:417-428.
44. Zimmerman A., Jyonouchi H., Comi A., Connors S., Milstien S., Varsou A., Heyes M. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr. Neurol. 2005, 35:195-201.
45. Zheng X., Chu F., Mirkin B.L., Thangirala S., Mousa S.A., Rebbaa A. Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy. Biochim. Biophys. Acta 2008, 1783(12):2294-2300.